Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes
2007

Quetiapine for Bipolar I Disorder

Sample size: 61 publication Evidence: moderate

Author Information

Author(s): Hardoy Maria Carolina, Garofalo Alessandra, Mellino Gisa, Tuligi Francesco, Cadeddu Mariangela, Carta Mauro Giovanni

Primary Institution: Center for Epidemiology and Clinical Practice in Mental Health ASL 7 Iglesias, Italy

Hypothesis

To assess the long-term response to add-on quetiapine therapy in patients with bipolar I disorder who were not adequately responding to standard medications.

Conclusion

Quetiapine treatment significantly reduced relapse rates of manic and depressive episodes in patients with bipolar I disorder.

Supporting Evidence

  • The annual relapse rate decreased from 2.09 episodes to 0.61 episodes after adding quetiapine.
  • The relative risk of relapse for all episodes was 3.4 before quetiapine treatment.
  • Patients were followed for an average of 15.7 months after starting quetiapine.

Takeaway

This study found that adding quetiapine to treatment helps people with bipolar I disorder have fewer mood episodes.

Methodology

Patients with bipolar I disorder inadequately responsive to ongoing medications were observed before and after receiving quetiapine.

Potential Biases

Potential bias due to the open-label design and lack of randomization.

Limitations

The study was open-label and lacked a control group.

Participant Demographics

61 patients, 41% male and 59% female, aged 18-68 years.

Statistical Information

P-Value

<0.001

Confidence Interval

95% CI 2.1–5.5

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1745-0179-3-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication